|
|
| News from
Sanmar Speciality Chemicals |
| |
Bonding
with Kalamazoo |
 |
| SSCL
ties up with Pharmacia |
| The Sanmar group’s association with
Kalamazoo, USA, through its joint venture with Flowserve Corporation
for manufacturing mechanical seals (the erstwhile Durametallic
Corporation) dates back to the year 1976. Now, after 25 years
here is an association with yet another company in Kalamazoo. |
| Sanmar Speciality Chemicals Limited (SSCL)
supplies 4-Methyl Acetophenone (4-MAP), an advanced pharmaceutical
intermediate for Celebrex, an anti-arthritic drug manufactured
by Pharmacia Corporation, Kalamazoo, USA (the erstwhile Monsanto
Searle). Pharmacia has qualified SSCL as an important vendor
for 4-MAP through a series of qualification audits. The first
of these audits was conducted in January 1997 and was followed
up with a facility inspection and a cGMP evaluation in April
and May 1999 respectively. |
| As part of its developmental efforts to meet
Pharmacia’s growing demand, SSCL set up a new 21-metre
high distillation column for fractional distillation. This column
with 15-metre structured Sulzer packing can produce high purity
products. Pharmacia has qualified this column for its performance
for supply of a high pure grade 4-MAP, towards futuristic requirements.
This qualification was through two facility audits, the first
one in March 2001 by Christian D Frank, Executive Director,
Global Procurement-Supply, Pharmacia Corporation and Harry Zafran
of D&O Pharmachem, USA and the second one in May 2001 by
Dr Mukund S Joshi, Senior Director, Global API Supply, Christian
D Frank and John H Symonds, Director, Chemical Procurement,
Pharmacia & Upjohn Company. These inspections were complemented
by an Environmental Safety and Health (ESH) audit by Gary J
Spies, Director-ESH, Pharmacia Corporation in May 2001. |
 |
| Christian D Frank, Executive Director, Global
Procurement-Supply, Pharmacia Corporation, USA and Harry Zafran
of D&O Pharmachem, USA, at the inauguration of the distillation
column. |
|
 |
| The imposing 21-metre high distillation column. |
 |
| The Pharmacia team at the new facility. |
|
 |
| C G Sethuram, Chief Executive, SSCL, explaining
a point to Gary J Spies, Director-ESH, Pharmacia Corporation,
USA, at the ESH audit. |
|
 |
| Dr Mukund S Joshi, Senior Director, Global API
Supply, Pharmacia, Christian D Frank and John H Symonds, Director,
Chemical Procurement, Pharmacia & Upjohn Company, with the SSCL
team. |
|
|
